Evidence map›Paper›PMID 35128030›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2022

Diet-induced Alzheimer's-like syndrome in the rabbit.

Craig Weiss, Nicola Bertolino, Daniele Procissi, Grazia Aleppo, Quinn C Smith, Kirsten L Viola, Samuel C Bartley, William L Klein, John F Disterhoft

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Diet-induced Alzheimer's-like syndrome in the rabbit.Alzheimer's & dementia (New York, N. Y.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Craig WeissDepartment of Neuroscience Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Nicola BertolinoDepartment of Radiology Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Daniele ProcissiDepartment of Radiology Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Grazia AleppoDivision of Endocrinology, Metabolism and Molecular Medicine Northwestern University, Feinberg School of Medicine Chicago Illinois USA.
Quinn C SmithDepartment of Neuroscience Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Kirsten L ViolaDepartment of Neurobiology Northwestern University Evanston Illinois USA.
Samuel C BartleyDepartment of Neurobiology Northwestern University Evanston Illinois USA.
William L KleinDepartment of Neurobiology Northwestern University Evanston Illinois USA.
John F DisterhoftDepartment of Neuroscience Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Northwestern University · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROGALSKI, EMILY J · 1996 to 2020
$28.9M
SLOW OUTWARD CURRENTS AND LEARNING IN AGING HIPPOCAMPUSR37AG008796 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DISTERHOFT, JOHN F · 1999 to 2020
$9.2M
Mechanisms of hippocampal network-targeted stimulation to rescue memory impairment due to Alzheimer's diseaseR01NS113804 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DISTERHOFT, JOHN F, VOSS, JOEL L · 2019 to 2023
$6.7M
SYNAPTIC SUBSTRATES OF AGE-DEPENDENT MEMORY DEFICITSR01AG017139 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DISTERHOFT, JOHN F · 1999 to 2013
$4.6M
Defining native proteoform landscape for amyloid-beta in Alzheimers diseaseRF1AG063903 · NIA · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L, KLEIN, WILLIAM L · 2019 to 2019
$2.9M
Synaptic substrates of age-dependent memory deficitsRF1AG017139 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DISTERHOFT, JOHN F, NICHOLSON, DANIEL A · 2016 to 2016
$2.9M
Northwestern University Postbaccalaureate Research Education ProgramR25GM121231 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ACOSTA, ANA MARIA · 2017 to 2024
$2.4M
Abeta oligomers (ADDLs)in Alzheimers Disease pathologyR01AG022547 · NIA · NORTHWESTERN UNIVERSITY · PI KLEIN, WILLIAM L · 2003 to 2010
$1.9M
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERSR01AG018877 · NIA · NORTHWESTERN UNIVERSITY · PI KLEIN, WILLIAM L · 2001 to 2003
$890k
Sporadic Alzheimer's Disease modeled with diabetes and high cholesterol in rabbitR56AG050492 · NIA · NORTHWESTERN UNIVERSITY · PI DISTERHOFT, JOHN F, KLEIN, WILLIAM L · 2018 to 2018
$762k
Physiological role of naturally-occuring amyloid beta oligomersR21AG060203 · NIA · NORTHWESTERN UNIVERSITY · PI KLEIN, WILLIAM L · 2018 to 2019
$416k
NCATS NIH HHS UL1 TR001422NIA NIH HHS P30 AG013854NIA NIH HHS R01 AG017139NIA NIH HHS R01 AG018877NIA NIH HHS R01 AG022547NIA NIH HHS R21 AG060203NIA NIH HHS R37 AG008796NIA NIH HHS R56 AG050492NIA NIH HHS RF1 AG017139NIA NIH HHS RF1 AG063903NIGMS NIH HHS R25 GM121231NINDS NIH HHS R01 NS113804
6 · The paper itself

Abstract

introductionAlthough mouse models of Alzheimer's disease (AD) have increased our understanding of the molecular basis of the disease, none of those models represent late-onset Alzheimer's Disease which accounts for >90% of AD cases, and no therapeutics developed in the mouse (with the possible exceptions of aduhelm/aducanumab and gantenerumab) have succeeded in preventing or reversing the disease. This technology has allowed much progress in understanding the molecular basis of AD. To further enhance our understanding, we used wild-type rabbit (with a nearly identical amino acid sequence for amyloid as in humans) to model LOAD by stressing risk factors including age, hypercholesterolemia, and elevated blood glucose levels (BGLs), upon an ε3-like isoform of apolipoprotein. We report a combined behavioral, imaging, and metabolic study using rabbit as a non-transgenic model to examine effects of AD-related risk factors on cognition, intrinsic functional connectivity, and magnetic resonance-based biomarkers of neuropathology.

methodsAging rabbits were fed a diet enriched with either 2% cholesterol or 10% fat/30% fructose. Monthly tests of novel object recognition (NOR) and object location memory (OLM) were administered to track cognitive impairment. Trace eyeblink conditioning (EBC) was administered as a final test of cognitive impairment. Magnetic resonance imaging (MRI) was used to obtain resting state connectivity and quantitative parametric data (R

resultsExperimental diets induced hypercholesterolemia or elevated BGL. Both experimental diets induced statistically significant impairment of OLM (but not NOR) and altered intrinsic functional connectivity. EBC was more impaired by fat/fructose diet than by cholesterol. Whole brain and regional R DISCUSSION: We propose that mechanisms underlying LOAD can be assessed by stressing risk factors for inducing AD and that dietary manipulations can be used to assess etiological differences in the pathologies and effectiveness of potential therapeutics against LOAD. In addition, non-invasive MRI in awake, non-anesthetized rabbits further increases the translational value of this non-transgenic model to study AD.

Indexed as

cholesteroldiabeteseyeblink conditioninglate onset Alzheimer's diseasemagnetic resonance imagingwhole‐brain R2*

Identifiers

PMID35128030
PMCPMC8804622
OpenAlexW4210697799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.